SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Rainsford KD. Aspirin and the salicylates. London: Butterworth & Company; 1984.
  • 2
    Brune K. The early history of non-opioid analgesics. Acute Pain 1997; 1: 3340.
  • 3
    Brune K. The concept of inflammatory mediators. In: ParnhamMJ, BruinvelsJ, editors. Discoveries in pharmacology. Vol. 2. Haemodynamics, hormones and inflammation. Amsterdam: Elsevier; 1984. p. 48798.
  • 4
    Williams G. The age of agony: the art of healing 1700–1800. London: Constable; 1975.
  • 5
    Sneader W. Drug discovery: the evolution of modern medicines. Chichester (UK): John Wiley & Sons; 1985.
  • 6
    Rinsema TJ. One hundred years of aspirin. Med Hist 1999; 43: 5027.
  • 7
    Serturner FW. Darstellung der reinen mohnsäure (opiumsäure) nebst einer chem: untersuchung des opiums. Tromsdorf J Pharm 1806; 14: 4793.
  • 8
    Bender GA. Great moments in pharmacy. Detroit: Northwood Institute Press; 1966.
  • 9
    Magendie F. Phénomènes physiques de la vie: leçons professées au collège de France. Paris: Chez Crochard; 1839.
  • 10
    Cahn A, Hepp P. Das Antifebrin, ein neues Fiebermittel. Centralbl Klin Med 1886; 7: 5614.
  • 11
    Tainter ML. Pain. Ann N Y Acad Sci 1948; 51: 311.
  • 12
    Dreser H. Pharmacologisches über aspirin (acetylsalicysaüre). Pflügers Arch Ges Phys 1899; 76: 30618.
  • 13
    Dreser H. Ueber modifizierte Salizylsäuren. Med Klin 1907; 14: 3903.
  • 14
    Kaufman DW, Kelly JP, Levy M, Shapiro S. The drug etiology of agranulocytosis and aplastic anemia. New York: Oxford University Press; 1991.
  • 15
    Dubach UC, Rosner B, Pfister E. Epidemiologic study of analgesics containing phenacetin—renal morbidity and mortality (1968–1979). N Engl J Med 1983; 308: 35762.
  • 16
    Shen TY. The proliferation of non-steroidal anti-inflammatory drugs (NSAIDs). In: ParnhamMJ, BruinvelsJ, editors. Discoveries in pharmacology. Vol. 2. Haemodynamics, hormones and inflammation. Amsterdam: Elsevier; 1984. p. 52353.
  • 17
    Wilhelmi G. Guinea-pig ultraviolet erythema test. Schweiz Med Wochenschr 1949; 79: 57780.
  • 18
    Irgapyrine. Ein Kompendium. Basel: J. R. Geigy; 1954.
  • 19
    Winter CA, Risley EA, Nuss GW. Carrageenin-induced edema in hindpaw of the rat as an assay for anti-inflammatory drugs. Proc Soc Exp Biol Med 1962; 111: 5447.
  • 20
    Randall LO, Selitto JJ. A method for measurement of analgesic activity on inflamed tissue. Arch Int Pharmacodyn Ther 1957; 111: 40919.
  • 21
    Adams SS. The propionic acids: a personal perspective. J Clin Pharmacol 1992; 32: 31723.
  • 22
    Lombardino JG. Enolic acids with anti-inflammatory activity. In: ScherrerRA, WhitehouseMW, editors. Medical chemistry: a series of monographs. New York: Academic Press; 1974. p. 12957.
  • 23
    Otterness IG, Larson DL, Lombardino JG. An analysis of piroxicam in rodent models of arthritis. Agents Actions 1982; 12: 30812.
  • 24
    Vane JR. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nat New Biol 1971; 231: 2325.
  • 25
    Brune K. How aspirin might work: a pharmacokinetic approach. Agents Actions 1974; 4: 2302.
  • 26
    Brune K, Lanz R. Pharmacokinetics of non-steroidal anti-inflammatory drugs. In: BontaIL, BrayMA, ParnhamMJ, editors. Handbook of inflammation. Vol. 5. Amsterdam: Elsevier; 1985. p. 41349.
  • 27
    Flower RJ. The development of cox-2 inhibitors. Nat Rev 2003; 2: 17991.
  • 28
    Brune K, Wagner K. The effect of protein/nucleic acid synthesis inhibitors on the inhibition of prostaglandin release from macrophages by dexamethasone. In: BruneK, BaggioliniM, editors. Arachidonic acid metabolism in inflammation and thrombosis. Agents Actions. (Suppl 4). Stuttgart: Birkhäuser; 1979. p. 737.
  • 29
    Fu JY, Masferrer JL, Seibert K, Raz A, Needleman P. The induction and suppression of prostaglandin H2 synthase (cyclooxygenase) in human monocytes. J Biol Chem 1990; 265: 1673740.
  • 30
    Masferrer JL, Zweifel BS, Seibert K, Needleman P. Selective regulation of cellular cyclooxygenase by dexamethasone and endotoxin in mice. J Clin Invest 1990; 86: 13759.
  • 31
    Kujubu DA, Fletcher BS, Varnum BC, Lim RW, Herschman HR. TIS10, a phorbol ester tumor promoter-inducible mRNA from Swiss 3T3 cells, encodes a novel prostaglandin synthase/cyclooxygenase homologue. J Biol Chem 1991; 266: 1286672.
  • 32
    Tegeder I, Lotsch J, Krebs S, Muth-Selbach U, Brune K, Geisslinger G. Comparison of inhibitory effects of meloxicam and diclofenac on human thromboxane biosynthesis after single doses and at steady state. Clin Pharmacol Ther 1999; 65: 53344.
  • 33
    Hinz B, Brune K. Cyclooxygenase-2—10 years later. J Pharmacol Exp Ther 2002; 300: 36775.
  • 34
    Feret B. Lumiracoxib: a cox-2 inhibitor for the treatment of arthritis and acute pain. Formulary 2003; 38: 52937.